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Abstract
Background: Oesophagectomy for cancers is a major operation with significant blood loss and usage.
Concerns exist about the side effects of blood transfusion, cost and availability of donated blood. We are
not aware of any previous study that has evaluated predictive factors for perioperative blood transfusion
in patients undergoing elective oesophagectomy for cancer.
This study aimed to audit the pattern of blood crossmatch and to evaluate factors predictive of transfusion
requirements in oesophagectomy patients.
Methods: Data was collected from the database of all patients who underwent oesophagectomy for
cancer over a 2-year period. Clinico-pathological data collected included patients demographics, clinical
factors, tumour histopathological data, preoperative and discharge haemoglobin levels, total blood loss,
number of units of blood crossmatched pre-, intra- and postoperatively, number of blood units transfused,
crossmatched units reused for another patient and number of blood units wasted.
Clinico-pathological variables were evaluated and logistic regression analysis was performed to determine
which factors were predictive of blood transfusion.
Results: A total of 145 patients with a male to female ratio of 2.5:1 and median age of 68 (40–85) years
were audited. The mean preoperative haemoglobin (Hb) was 13.0 g/dl. 37% of males (Hb < 13.0 g/dl) and
29% of females (Hb < 11.5 g/dl) were anaemic preoperatively. A total of 1241 blood units were
crossmatched and 316 units were transfused to 71 patients. Seventy four patients (51%) did not require
blood transfusion during their hospital episode. 846 blood units not used for oesophagectomy patients
were reused for other patients and 79 units were wasted. The overall crossmatch to transfusion ratio was
4:1 and reuse and wastage rates were 65.2% and 6.3% respectively. The independent predictors of blood
transfusion include age >70 years, Hb level <11.0 g/dl, T-stage, presence of postoperative complications
and anastomotic leak.
Conclusion:  The cohort of patients audited was over-crossmatched. The identified independent
predictors of blood transfusion should be considered in preoperative blood ordering for oesophagectomy
patients. This study has directly led to a reduction in the maximum surgical blood-ordering schedule for
oesophagectomy to 2 units and a reaudit is underway.
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Background
Oesophageal cancer is the eighth leading cancer and the
sixth leading cause of death from cancer worldwide. The
prognosis for oesophageal cancer is poor and there has
been an alarming rise in the incidence [1-3]. Anaemia is
the most frequently observed haematological abnormal-
ity in cancer patients and occurs in about 30% of patients
with oesophagogastric cancers (OGC) [4]. Our experience
in Nottingham has shown that up to two-third of our
patients presented with some degree of anaemia at the
diagnosis of their cancer. We were able to demonstrate in
a recent pilot study that more than half of newly diag-
nosed patients with gastric or oesophageal cancers were
iron deficient [5].
Cancer-related anaemia is usually caused by multiple fac-
tors. The disease itself through blood loss and poor die-
tary intake due to dysphagia, anorexia and vomiting can
cause anaemia in patients with cancer. Anaemia of
chronic disease specific to cancer patients is believed to be
due to activation of the immune and inflammatory path-
ways leading to release of cytokines [6,7]. It can also be
exacerbated by side effects of treatment such as cytotoxic
chemotherapy as a result of myelosuppression, suppres-
sion of erythropoietin production and/or a reduction in
bone marrow response to erythropoietin [6]. Most
patients with oesophagogastric cancers require operation
to remove their cancer and this involves further blood
loss. Sutton et al [8] have previously shown that
oesophagectomy with extensive lymphadenectomy are
usually accompanied by blood transfusion more com-
monly than radical operations for other gastrointestinal
cancers. Anaemia can compound and delay recovery from
such surgical procedure and the presence of anaemia prior
to operation is associated with increase complication rates
and transfusion requirements [9].
Blood transfusion is a rapid method of correcting anaemia
and currently one of the common forms of treatment
offered to cancer patients. However, concerns have been
raised about the side effects of transfusion, cost and avail-
ability of donated blood [10]. The indications and trigger
for blood transfusion have been redefined in the last dec-
ade so as to ensure that blood and blood products are con-
sidered and treated as medications in their own merit
[11]. There is evidence that perioperative blood transfu-
sion has immunomodulatory effect and adversely affects
outcome in patients undergoing oesophagectomy for can-
cer [12]. We are not aware of any previous study that has
evaluated predictive factors for perioperative blood trans-
fusion in patients undergoing elective oesophagectomy
for cancer.
This study aimed to audit the pattern of blood crossmatch
and transfusion requirements in patients undergoing
oesophagectomy for cancer. We evaluated the reuse and
wastage rates of the blood primarily crossmatched for
oesophagectomy patients and identified possible factors
predictive of perioperative blood transfusion in our
cohort of patients.
Methods
Data was retrospectively collected from a database of all
patients who underwent elective oesophagectomy for can-
cer at our institution between January 2003 and Decem-
ber 2004. The approval for this study was granted by the
Nottingham City Hospital Audit and Clinical Governance
Department. Operative procedures were carried out
through a two-phase approach for oesophagectomy and a
two-field lymphadenectomy. Clinico-pathological and
laboratory data for these patients was obtained from our
unit, the Hospital Information Support System (HISS),
the blood bank databases and Patient Administration Sys-
tem (PAS). Clinico-pathological data collected included
patients demographics, clinical factors, tumour his-
topathological data, preoperative and discharge haemo-
globin levels, operative blood loss, number of units of
blood crossmatched pre-, intra- and post-operatively,
number of blood units transfused, crossmatched units
reused for another patient and number of blood units
wasted.
This audit covered the period when the recommended
routine preoperative crossmatching by our Oesoph-
agogastric unit for oesophagectomy was 4–6 units. Anae-
mia was defined on the basis of haemoglobin levels below
the lower limit of normal for our laboratory reference val-
ues in accordance with the World Health Organization
(WHO) criteria [13] with Hb < 13.0 g/dl in males and
<11.5 g/dl in females. Total blood loss was calculated as
the sum of intraoperative blood measured by the anaes-
thesiologist according to the contents of the suction bot-
tles & the weight change of surgical swabs and
postoperative blood loss. The criteria used as guidelines
for blood transfusion in our unit during the audited
period included significant blood loss >800 ml, haemody-
namic instability or persistent postoperative haemoglobin
<8.0 g/dl. The total blood loss and transfusion require-
ments were compared between anaemic and non-anae-
mic patient groups. We then evaluated the effect of
various clinico-pathological factors on blood transfusion
requirements.
Statistical analysis
Statistical analysis was performed using the SPSS version
13.0 for windows-software (SPSS, Chicago, Illinois, USA)
to present descriptive statistics. The mean and median val-
ues were calculated for continuous and discrete variables
respectively. Univariate and multivariate analyses were
performed to determine the risk factors for blood transfu-BMC Surgery 2008, 8:3 http://www.biomedcentral.com/1471-2482/8/3
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sion. Statistical significance was tested using Mann-Whit-
ney U-test or student t-test where appropriate. Variables
that demonstrated a significant relationship on univariate
analysis were included in a multiple stepwise logistic
regression analysis to identify the significant independent
predictors of blood transfusion. The level of significance
was set at p-value less than 0.05.
Results
A total of 145 consecutive patients were included in the
study with 104 males and 41 females (Male: Female ratio
of 2.5:1). The median age was 68 (40–85) years. The pre-
dominant histological type was adenocarcinoma (107)
compared with squamous cell carcinoma (38). The mean
pre-operative haemoglobin (Hb) was 13.0 (9–17.5) g/dl.
Of the male group, 39 patients (37.5%) were anaemic pre-
operatively (Hb < 13.0 g/dl) and 12 patients (29.7%) of
the female group were anaemic preoperatively (Hb < 11.5
g/dl). There was no difference in the distribution of co-
morbid factors between the anaemic and non-anaemic
groups. The mean discharge Hb was 11.0 (7.9 – 15.6) g/
dl. The median operative blood loss was 700 ml (150 –
2400) with a mean of 849 ml and there was no significant
difference between the anaemic and non-anaemic
patients (p = 0.343). Forty-four percent of the patients had
neoadjuvant chemotherapy and there was no significant
difference in operative blood loss between this group and
those who did not receive neoadjuvant chemotherapy.
A total of 1241 blood units were crossmatched and 74%
were performed preoperatively, 3% between intra-opera-
tive period to 48 hours postoperatively and 23% from 48
hours postoperatively to discharge. The median number
of blood units crossmatched from the preoperative period
to discharge was 6 (0 – 34) units with a mean of 8.6 units.
The median number of blood units crossmatched preop-
eratively was 6 (0 – 23) units with a mean of 6.3 units. The
median number of blood units crossmatched from the
start of the operation to 48 hours postoperatively was 0 (0
– 7) units with a mean of 0.3 unit. The median number of
blood units crossmatched from 48 hours postoperatively
to discharge was 0 (0 – 30) units with a mean of 2.0 units.
Thirty-nine percent of the patients had multiple peri-oper-
ative blood crossmatch over the upper limit of 6 units that
was routinely performed during the audited period and
the reasons are outlined in Table 1.
Forty-nine percent (71/145) of the patients were trans-
fused with a total of 316 blood units. Ninety-six percent
of the transfusions occurred between intraoperative
period and discharge (Figure 1). The median number of
blood transfused was 4 (1 – 18) units with a mean of 4.5
units in this group of patients. Median operative blood
loss was higher in patients who were transfused than
those that were not transfused but the difference did not
reach a statistical significance (p-value = 0.168). The risk
factors for perioperative blood transfusion on univariate
analysis are shown in Table 2. The independent predictors
of blood transfusion are age more than 70 years, Hb level
less than 11.0 g/dl, T-stage, presence of perioperative com-
plications and anastomotic leak (Table 3). There was no
difference between the two groups in relation to gender,
tumour location, histology, differentiation, and lymph
node involvement. A direct correlation between the sever-
ity of preoperative anaemia and perioperative blood
transfusion requirements was observed in spite of similar
operative blood loss in the two groups (p = 0.013).
A total of 846 blood units that were crossmatched prima-
rily for oesophagectomy patients were reused for another
group of patients and 79 blood units were wasted overall.
The overall crossmatch to transfusion ratio (C/T ratio) was
4:1 with overall reuse and wastage rates of 65.2% and
6.3% respectively. C/T ratio was significantly higher in
patients who had six or less number of blood units cross-
matched compared with patients with more than six units
crossmatched (C/T ratio 8.5:1 versus 2.8:1; p = 0.001).
Table 1: Reasons for multiple blood ordering of more than six units in 56 patients
1. Severe anaemia requiring preoperative top up transfusion
2. Operation cancellation
(i) Medical reasons
(ii) Unavailability of intensive care unit bed
3. Excessive intraoperative bleeding
4. Reoperation
(i) Ischaemic anastomotic site or bowel
(ii) Postoperative bleeding
(iii) Chyle leak
(iv) Massive gastrointestinal bleeding
(v) Empyema
5. Postoperative complications
(i) Anastomotic leak
(ii) Postoperative bleeding
(iii) SepsisBMC Surgery 2008, 8:3 http://www.biomedcentral.com/1471-2482/8/3
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The wastage rate was twice as high in the former compared
with the latter patient groups (9% versus 4.5%).
Discussion
Surgery is still the main treatment option for oesophageal
cancer and recent advances in surgical and anaesthetic
techniques with improvements in postoperative care have
reduced the risks of oesophageal resection to an accepta-
ble level. It has been reported that oesophagectomy with
extensive lymphadenectomy is usually accompanied by
blood transfusion more commonly than radical opera-
tions for other gastrointestinal cancers [8,12]. It is there-
fore customary that patients planned for oesophagectomy
for cancer are routinely grouped and crossmatched so as
to ensure that blood is readily available during and imme-
diately after the operation. There have been several studies
in the last three decades reviewing blood ordering and
transfusion practices on account of gross over ordering of
blood much in excess of actual or anticipated needs [14-
17]. These studies resulted from increasing demand for
blood and blood products together with rising costs and
increased public and medical concerns regarding transfu-
sion-associated infections and immunosuppression.
Surgical indications have been shown to account for more
than half of red cells blood transfusion in the United
States [18]. However, it is known that many units of blood
routinely ordered for surgery are never utilised, resulting
in extra workload for laboratory staff and expenses for the
blood banks [15-17]. Such blood units are held in reserve
and therefore not immediately available for other
patients, which can lead to loss of shelf life and eventual
wastage. The cost of blood transfusions to the National
Health Service (NHS) in 2000/2001 was estimated to be
£898 millions, representing a 256% increase since 1994/
1995 in the UK [19]. The demand for blood and blood
products has been predicted to increase by 4.9% by 2008
[20]. The increasing demand for blood, increase in ageing
population, possible fall in the donor pool and introduc-
tion of further screening tests for donated blood will lead
to scarcity and further increase in the costs of blood trans-
fusion [19,20].
This is the first study to the best of our knowledge that
evaluated predictive clinico-pathological factors for blood
transfusion in patients undergoing elective oesophagec-
tomy for cancer. Four to six units of blood were routinely
crossmatched preoperatively for patients undergoing
oesophagectomy for cancer at the time covered by this
audit in our unit. Significant number of our patients had
preoperative anaemia. Our median operative blood loss
of 700 ml and transfusion rate are comparable to those
reported in the literature [12]. There was no statistically
significant difference between the operative blood loss
between the anaemic and non-anaemic patients. Patients
who were older than 70 years had significantly more ten-
dency for perioperative blood transfusion and we believe
this may be related to the presence of more co-morbid fac-
tors in them than the younger patients. The younger
patients understandably may also have more appropriate
physiological compensatory mechanisms to blood loss
than the older group.
Our results showed that the number of blood units cross-
matched significantly exceeded that which was actually
transfused to the patients. Forty-nine percent of our
patients were transfused with a mean of 4.5 units and only
a third of these patients had more than five units of blood
transfused. This finding supports previous reports point-
Pie chart showing the time period of perioperative blood  transfusion in patients undergoing oesophagectomy Figure 1
Pie chart showing the time period of perioperative blood 
transfusion in patients undergoing oesophagectomy.
59.15%
36.62%
4.23%
Period 48 hours after
surgery until discharge
Intraoperative to 48
hours after surgery
Preoperative period
Table 3: Independent predictors of blood transfusion by logistic regression analysis
Factor p-value RR 95% Confidence Interval
Age >70 years 0.044 2.328 1.022 – 5.304
Hb level <11.0 g/dl 0.0001 3.225 1.797 – 5.786
T-stage 0.004 2.436 1.249 – 5.762
Perioperative complications 0.015 2.801 1.219 – 6.436
Anastomotic leak 0.028 14.545 1.331 – 158.903
RR, Relative riskBMC Surgery 2008, 8:3 http://www.biomedcentral.com/1471-2482/8/3
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Table 2: Risk factors for perioperative blood transfusion in 145 patients undergoing oesophagectomy
Factors Transfused (71) Not transfused (74) P-value
Sex: 0.148
Male 47 57
Female 24 17
Age: 0.0001
<70 years 31 54
>70 years 40 20
Comorbid factors: 0.002
Yes 45 28
No 26 46
ASA Class: 0.004
18 1 8
24 4 4 8
31 9 8
ECOG score: 0.005
02 7 4 5
13 1 2 3
21 0 4
33 2
Haemoglobin levels: 0.001
<11.0 g/dl 15 2
≥ 11.0 g/dl 56 72
Tumour site: 0.836
Upper third 1 1
Middle third 8 6
Lower third 18 16
GOJ 44 51
Neoadjuvant chemotherapy: 0.266
Yes 28 36
No 43 38
Tumour histology: 0.200
SCC 22 16
ADC 49 58
Tumour grade: 0.870
Well 12 13
Moderately 26 25
Poorly 33 36
T-stage: 0.002
15 1 6
29 1 6
35 5 4 2
42 0
N-stage: 0.166
N0 34 27
N1 37 47
Operative blood loss: 0.715
<800 ml 43 47
>800 ml 28 27
Postoperative complications: 0.0001
Yes 46 25
No 25 49
Anastomotic leak: 0.001
Yes 13 1
No 58 73
ECOG, Eastern Cooperative Oncology Group; GOJ, Gastro-oesophageal junction;
SCC, Squamous cell carcinoma; ADC, AdenocarcinomaBMC Surgery 2008, 8:3 http://www.biomedcentral.com/1471-2482/8/3
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ing to the tendency to over crossmatching of blood for
patients undergoing major operations [15-17]. The British
Committee for Standards in Haematology (BCSH) formu-
lated guidelines stating that, in general, the ratio of the
number of blood units ordered and transfused should not
normally exceed 2:1 [21]. The overall crossmacth to trans-
fusion ratio was twice the recommended value by the
BCSH and in fact fifty-two percent of the transfused
patients in this study had blood crossmatched to transfu-
sion ratio above 2:1. This evidently showed that the
cohort of patients audited was over-crossmatched and this
study has directly led to a reduction in the maximum sur-
gical blood ordering schedule (MSBOS) for oesophagec-
tomy to 2 units. Palmer et al [17] have previously reported
that a patient-specific blood ordering system (PSBOS) is
more accurate in predicting potential perioperative blood
transfusion. Sixty-eight percent of the unused blood pri-
marily crossmatched for our oesophagectomy patients
were subsequently reused for other patients but still, 6.3%
of blood units were wasted. This wastage rate falls within
the reported rates by previous authors [22,23]. A signifi-
cant proportion of the wastage in this study was due to
expiration of the shelf life of blood units.
The adoption of PSBOS approach has the potential and
capacity to reduce the workload in the transfusion labora-
tories, reduce cost, conserve already scarce blood
resources and prevent unnecessary blood transfusion and
wastage. The rational way to minimize blood wastage and
reduce the crossmatch to transfusion ratio is by more pre-
cisely predicting and estimating an individual patient's
likelihood of requiring transfusion perioperatively. We
have evaluated and identified some independent factors
that are predictive of patients' likelihood of blood transfu-
sion requirements such as age above 70 years, preopera-
tive haemoglobin less than 11.0 g/dl, locally advanced
tumour, the presence of perioperative complications espe-
cially postoperative sepsis and anastomotic leak. The
results of this audit support other previous studies
[15,16,21,24,25]. The current study demonstrated no
relationship between the need for blood transfusion and
gender, tumour site, histology, differentiation, nodal
involvement and the use of neoadjuvant chemotherapy.
The local Hospital Transfusion Committee (HTC) may be
able to monitor the effectiveness of the blood requesting
policy using the crossmatch to transfusion ratio. Preoper-
ative strategies should incorporate blood ordering services
aimed at reducing over crossmatch and avoid wastage of a
scarce resource. Greater precision in crossmatch to trans-
fusion ratio can be further improved by careful estimation
of an individual patient's likelihood of having blood
transfusion perioperatively through the application of
identified clinico-pathological and operative risk factors.
This approach is likely to address the issues of demand
versus supply under the current circumstances of concerns
relating to the costs, safety of blood and blood products.
Improvements and advances in surgical and anaesthetic
techniques with better perioperative care may therefore
mean that fewer patients are requiring blood transfusion
following their operation.
Thirty-nine percent of our patients had multiple perioper-
ative blood crossmatch whereby there were several
instances when blood sample was sent for one or more
units of blood to be crossmatched. The reasons for this
practice included operation cancellations, severe preoper-
ative anaemia necessitating transfusion before surgery and
perioperative complications. Complications leading to
multiple blood crossmatch and transfusions were anasto-
motic leakage, sepsis, reoperation for various reasons and
postoperative bleeding. The crossmatch to transfusion
ratio was significantly lower (C/T ratio 2.8:1 versus 8.5:1)
and wastage rates was half (4.5% versus 9%) in patients
who had multiple crossmatch compared with those with
six or less units of blood crossmatched. We do agree with
Palmer et al [17] that an individual patient-specific blood
ordering system may be more accurate in reducing unnec-
essary crossmatch than the maximal surgical blood order-
ing system. PSBOS can only be effectively applied by
predicting the likelihood of an individual patient risk of
receiving blood transfusion in the course of their hospital
episode for elective operations. Varney and Guest [19] in
an economic study of the annual cost of blood transfu-
sions in the UK for 2000/2001 estimated that the average
cost of an adult transfusion of a unit of red blood cells to
the NHS was £635. The estimated cost of a unit of red
blood cells including the laboratory services in our hospi-
tal is £132 and this, when calculated for 79 units of blood
wasted in this audit will translate into a total of £10,428.
Conclusion
The cohort of patients audited in this study was over-
crossmatched. The future trends are likely to be related to
major changes in the blood ordering and transfusion
practice as a result of effect of demand versus supply,
evolving surgical and anaesthetic techniques, redefinition
of more objective transfusion triggers, availability of pos-
sibly cheaper alternatives to blood and blood products
and the public's and clinicians' perceptions of safety of
blood transfusion. The rising costs of blood transfusion
and potential reduction in donor pool make it imperative
for us to continue to utilise the scarce blood resources
more effectively. The identified independent predictors of
blood transfusion should be considered in preoperative
blood ordering for patients undergoing oesophagectomy.
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